James Meyer

944 total citations
12 papers, 739 citations indexed

About

James Meyer is a scholar working on Surgery, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, James Meyer has authored 12 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in James Meyer's work include Muscle Physiology and Disorders (4 papers), Anesthesia and Pain Management (2 papers) and Pediatric Pain Management Techniques (2 papers). James Meyer is often cited by papers focused on Muscle Physiology and Disorders (4 papers), Anesthesia and Pain Management (2 papers) and Pediatric Pain Management Techniques (2 papers). James Meyer collaborates with scholars based in United States and Canada. James Meyer's co-authors include Gary A. Cline, J-P Pelletier, Johanne Martel‐Pelletier, Boulos Haraoui, D. Choquette, G. Beaudoin, Roy D. Altman, D. Blöch, M.C. Hochberg and John F. Beary and has published in prestigious journals such as Neurology, Biological Psychiatry and Annals of the Rheumatic Diseases.

In The Last Decade

James Meyer

12 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Meyer United States 6 473 422 182 181 118 12 739
Yorikazu Akatsu Japan 15 306 0.6× 282 0.7× 61 0.3× 164 0.9× 89 0.8× 38 642
Patrick N. Siparsky United States 12 379 0.8× 272 0.6× 81 0.4× 101 0.6× 58 0.5× 19 665
Esther Roselló-Sastre Spain 14 234 0.5× 150 0.4× 254 1.4× 239 1.3× 45 0.4× 23 612
Fiona Scott Australia 11 672 1.4× 880 2.1× 524 2.9× 179 1.0× 29 0.2× 12 1.1k
Christian Egloff Switzerland 14 304 0.6× 271 0.6× 227 1.2× 170 0.9× 41 0.3× 50 587
Yoshiharu Shimozono United States 23 466 1.0× 199 0.5× 344 1.9× 924 5.1× 97 0.8× 71 1.3k
N.E. Lane United States 12 285 0.6× 369 0.9× 172 0.9× 84 0.5× 33 0.3× 13 533
Yasuo Morio Japan 20 753 1.6× 143 0.3× 73 0.4× 156 0.9× 96 0.8× 47 1.1k
Tricia Hubbard‐Turner United States 11 229 0.5× 170 0.4× 265 1.5× 638 3.5× 48 0.4× 34 869
Shuji Taketomi Japan 20 1.0k 2.1× 140 0.3× 119 0.7× 349 1.9× 57 0.5× 132 1.3k

Countries citing papers authored by James Meyer

Since Specialization
Citations

This map shows the geographic impact of James Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Meyer more than expected).

Fields of papers citing papers by James Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Meyer. The network helps show where James Meyer may publish in the future.

Co-authorship network of co-authors of James Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of James Meyer. A scholar is included among the top collaborators of James Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Meyer. James Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
3.
Dubow, Jordan & James Meyer. (2016). Corticosteroids in Duchenne Muscular Dystrophy—A Deflazacort Review. 12(1). 12–12. 1 indexed citations
4.
Griggs, Robert C., J. Philip Miller, Cheryl R. Greenberg, et al.. (2016). Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy. Neurology. 87(20). 2123–2131. 104 indexed citations
6.
Dubow, Jordan, et al.. (2016). Effect of deflazacort and prednisone on muscle enzymes in the treatment of Duchenne muscular dystrophy. Neuromuscular Disorders. 26. S180–S180. 1 indexed citations
7.
Schmitz, Michael L., William T. Zempsky, & James Meyer. (2015). Safety and Efficacy of a Needle-free Powder Lidocaine Delivery System in Pediatric Patients Undergoing Venipuncture or Peripheral Venous Cannulation: Randomized Double-blind COMFORT-004 Trial. Clinical Therapeutics. 37(8). 1761–1772. 7 indexed citations
8.
Zempsky, William T., Michael L. Schmitz, & James Meyer. (2015). Safety and Efficacy of Needle-free Powder Lidocaine Delivery System in Adult Patients Undergoing Venipuncture or Peripheral Venous Cannulation. Clinical Journal of Pain. 32(3). 211–217. 5 indexed citations
9.
Raynauld, J. P., Johanne Martel‐Pelletier, F. Abram, et al.. (2007). Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period. Annals of the Rheumatic Diseases. 67(5). 683–688. 162 indexed citations
10.
Martel‐Pelletier, Johanne, G. Beaudoin, D. Blöch, et al.. (2004). Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Annals of the Rheumatic Diseases. 64(4). 556–563. 445 indexed citations
11.
Spector, Tim D., et al.. (2003). Risedronate produces disease modification and symptomatic benefit in the treatment of knee osteoarthritis: results from the BRISK study. Research Portal (King's College London). 48(12). 3650–3651. 8 indexed citations
12.
Meyer, James, Sidney H. Kennedy, Richard P. Swinson, Sylvain Houle, & Geri Brown. (1996). Altered response to intravenous d-fenfluramine during depression using [15O]-PET. Biological Psychiatry. 39(7). 516–516. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026